For off-label weight loss use, most providers follow criteria requiring BMI of 30 or higher (obesity), or BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, high cholesterol, sleep apnea, prediabetes, or cardiovascular disease
Mendelsohn added that patients could choose to have the implant removed at any time, after which drug exposure would decline relatively quickly
doi: 10.1016/j.cell.2014.11.047 101 YanoJ
Skipping the titration regimen and starting Wegovy with the 1.7 mg dose may cause severe GI side effects, and prolonged vomiting and diarrhea can lead to dehydration
How soon will I see results from XERF
Q: Can I take these while using GLP-1 medications